Document LJjR35JKBYrbGZee2OmRab8B3

NORTHERN KENTUCKY OFFICE SUITE 340 1717 DIXIE HIGHWAY COVINGTON, KENTUCKY 41011-4704 606-331-2838 513-381-2838 FAX: 513-381-6613 DAYTON, OHIO OFFICE SUITE 900 110 NORTH MAIN STREET DAYTON, OHIO 45402-1786 937-228-2838 FAX: 937-228-2816 Roberta. Bilott (513)357-9638 bilott@taftlaw.com TAFT, STETTINIUS & HOLLISTER LLP 425 WALNUT STREET, SUITE 1800 CINCINNATI, OHIO 45202-3957 513-381-2838 FAX: 513-381-0205 www.taftlaw.com geHQ- og- 00373 August 7, 2003 ^ I W J, CLEVELAND, OHIO OFFICE 3500 BP TOWER 200 PUBLIC SQUARE CLEVELAND, OHIO 44114-2302 216-241-2838 FAX: 216-241-3707 COLUMBUS, OHIO OFFICE 21 EAST STATE STREET COLUMBUS, OHIO 43215-4221 614-221-2838 FAX:614-221-2007 C-..' TELECOPY AND FEDERAL EXPRESS wcr Richard H. Hefter, Chief High Production Volume Chemicals Branch U.S. Environmental Protection Agency Office of Pollution Prevention and Toxics 1200 Pennsylvania Avenue, N.W. Washington, D.C. 20460-0001 Document Processing Center (7407M) EPA East - Room 6428 Attn: Section 8(e) U.S. Environmental Protection Agency Office of Pollution Prevention and Toxics 1200 Pennsylvania Avenue, N.W. Washington, D.C. 20460-0001 Re: TSCA Section 8(e) Reporting For PFOA & epa- ots 000811865T Dear Mr. Hefter: DOallbST As a further supplement to our July 3, July 31, aitid August 5, 2003, letters on the referenced topic, we have enclosed a copy of a C-8 blood model developed by E.I. duPont de Nemours and Company ("DuPont"), which relates to DuPont's knowledge of estimated levels of perfluorooctanoate concentrations in the blood of the communities exposed to DuPont's C-8 emissions in air and water, as of October 10, 2001. truly yours RAB:mdm Robert A. Bilott cu 3 Enclosure cc: Dr. Charles M. Auer (USEPA OPPT) (w/o end.) 47- -"--oOimmO Mary Dominiak (USEPA OPPT) (for inclusion in AR-226) (w/ end.) Jennifer Seed (USEPA) (w/ end.) R. Edison Hill, Esq. (w/ end.) x tc X 2m c5 o o Larry A. Winter, Esq. (w/ end.) Gerald J. Rapien, Esq. (w/o end.) Contain No^BI W0034692.1 1